Benznidazole is an antiparasitic medication used in the treatment of Chagas disease. While it is highly effective in early disease, the effectiveness decreases in those who have long-term infection. From Wikipedia
The agency argues formal recognition would trigger stronger surveillance alongside earlier treatment.
